ANNE ALBIEZ: Open Payments
NPI 1609868579 · BRICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,110 in 104 payments from 10 companies in 2025. Trend: 2023 $1,311 · 2024 $1,732 · 2025 $2,110
Food & beverage: $2,110
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 28 | $426 |
| Otsuka America Pharmaceutical, Inc. | 13 | $318 |
| Alkermes, Inc. | 10 | $282 |
| Neurocrine BioSciences, Inc. | 17 | $279 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $264 |
| E.R. Squibb & Sons, L.L.C. | 13 | $209 |
| Vanda Pharmaceuticals Inc. | 7 | $120 |
| Axsome Therapeutics, Inc. | 1 | $110 |
| Lundbeck LLC | 5 | $87 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: AUSTEDO XR, REXULTI, INGREZZA, CAPLYTA, ARISTADA, COBENFY, FANAPT, Auvelity.
Industry payments across NJ — which companies pay providers there.
